Carregant...
Production of [(211)At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Therapy
(211)At is a promising radionuclide for α-particle therapy of cancers. Its physical characteristics make this radionuclide particularly interesting to consider when bound to cancer-targeting biomolecules for the treatment of microscopic tumors. (211)At is produced by cyclotron irradiation of (209)Bi...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mary Ann Liebert, Inc.
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3545490/ https://ncbi.nlm.nih.gov/pubmed/23075373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2012.1292 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|